Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222 for AstraZeneca sponsored clinical trials.   Under the agreement, Symbiosis will provide AstraZeneca fast-track access to sterile vaccine drug product manufacturing capacity for clinical trial supply.   The agreement follows AstraZeneca’s recent anno...